The Link Between Dexamethasone And Stroke Risk

can dwxamethasone cause a stroke

Dexamethasone is a prescription medication that comes in the form of an oral tablet, oral solution, eye drops, ear drops, and an injectable solution. It is used to treat various conditions, including inflammation, allergic reactions, flare-ups of ulcerative colitis, and adrenal insufficiency. While dexamethasone has been found to be effective in treating COVID-19 patients requiring respiratory support, its use has been associated with certain side effects and risks. For instance, it may cause an allergic reaction, heart damage, and infections. Additionally, long-term use can lead to eye problems and increase the risk of osteoporosis. Regarding its impact on stroke, studies have shown conflicting results. While some research suggests that dexamethasone can improve the level of consciousness in acute ischemic stroke associated with brain edema, other studies have found no significant difference in the numbers of survivors or the quality of life between patients treated with dexamethasone or a placebo. Thus, there is currently insufficient evidence to determine the benefits of dexamethasone in treating acute ischemic stroke.

Characteristics Values
Dexamethasone's effect on stroke A double-blind study found that dexamethasone improved the functional status of patients with severe strokes by 12% on average. However, another study found no significant difference in the number of survivors or quality of life between patients treated with dexamethasone or a placebo.
Dexamethasone's effect on brain oedema Dexamethasone improved the level of consciousness in acute ischemic stroke associated with brain oedema but did not reduce the volume of the hypodense area.
Dexamethasone's effect on reducing brain swelling Corticosteroids, including dexamethasone, have been used to reduce brain swelling after a stroke to limit damage and speed up recovery. However, a review of eight trials found no benefit of corticosteroids in reducing deaths or improving functional outcomes.

medshun

Dexamethasone's impact on brain oedema after acute ischaemic stroke

Dexamethasone is a corticosteroid that has been used to reduce brain swelling and improve recovery from acute ischaemic stroke. Ischaemic cerebral tissue tends to develop cytotoxic oedema, which can be followed by vasogenic oedema if the blood-brain barrier is disrupted. Large infarcts can lead to life-threatening massive oedema.

A randomised clinical trial assessed the effects of dexamethasone on brain oedema following acute ischaemic stroke. The study included 60 patients divided into two groups, with 30 patients each in the experimental and control groups. The level of consciousness was compared using the Glasgow Coma Scale (GCS) on the 3rd, 7th, and 10th days of intervention, and improvement was found in both groups. However, the improvement in the level of consciousness was more significant in the dexamethasone-treated group. While dexamethasone improved the level of consciousness in acute ischaemic stroke associated with brain oedema, it did not reduce the volume of the hypodense area, as observed in CT scans before and after treatment.

Another double-blind study conducted at the Neurological Institute of New York found that dexamethasone improved functional status in patients with severe strokes. The results suggested that the beneficial effects of dexamethasone may be due to its ability to decrease brain oedema secondary to massive brain infarction.

However, a review of eight trials involving 466 participants found no evidence of benefit from corticosteroids in reducing deaths or improving functional outcomes in survivors of acute ischaemic stroke. The small amount of evidence available does not support the use of corticosteroids as a routine treatment for acute ischaemic stroke.

medshun

Dexamethasone's influence on the level of consciousness

Dexamethasone is a potent synthetic analogue of cortisol, which is used to treat inflammation, asthma, bronchitis, and acute croup in children. It is also used in the prevention and treatment of nausea and vomiting after chemotherapy.

Dexamethasone has been found to influence the level of consciousness in patients with acute ischemic stroke. A study conducted on 60 patients found that the level of consciousness improved in both the dexamethasone-treated group and the control group. However, the improvement was statistically significant in the dexamethasone-treated group when compared using the Glasgow Coma Scale (GCS) on the 3rd, 7th, and 10th days of intervention.

Another double-blind study involving 31 patients with acute stroke found that those treated with dexamethasone improved their functional status by an average of 12% during the treatment period, while those treated with a placebo got worse by 12%. The benefit of dexamethasone was more pronounced in the 15 patients most severely affected by their stroke, with the treated group improving by 23% and the placebo group worsening by 14%. These results were statistically significant.

The beneficial effects of dexamethasone on the level of consciousness in acute ischemic stroke may be due to its ability to decrease brain edema, which is a common complication of stroke. However, it is important to note that the evidence regarding the effectiveness of dexamethasone in acute ischemic stroke is limited, and more research is needed to draw definitive conclusions.

medshun

Dexamethasone's effect on the volume of hypodense areas in the brain

Dexamethasone is a corticosteroid used to treat brain oedema and reduce intracranial pressure in patients with brain tumours or acute ischemic stroke. It is also used after brain surgery, particularly in patients with significant mass effects.

A 2011 randomised clinical trial assessed the effects of dexamethasone on brain oedema following acute ischemic stroke. The study included 60 patients divided into two groups based on age, sex, and stroke severity. The level of consciousness was compared using the Glasgow Coma Scale (GCS) on the 3rd, 7th, and 10th days of intervention, showing significant improvement in the dexamethasone-treated group. However, the volume of hypodense areas in the brain, as seen on CT scans before and after treatment, did not differ significantly between the dexamethasone and control groups (p=0.74). This indicates that dexamethasone improved the level of consciousness in acute ischemic stroke with brain oedema but did not reduce the volume of hypodense areas.

Another study by Shaikh et al. in 2011 supports these findings. They found that dexamethasone improved the level of consciousness in patients with acute ischemic stroke and brain oedema. However, they also reported no significant difference in the volume of hypodense areas between the dexamethasone and control groups.

In contrast, a double-blind study by Patten et al. in 1972 suggested that dexamethasone improved functional status in patients with severe strokes, attributing the beneficial effects to a potential reduction in brain oedema. However, this study had a smaller sample size, with 14 patients treated with dexamethasone and 17 with a placebo.

A 2020 prospective-observational study by Moll et al. investigated the effects of dexamethasone on traumatic brain injury patients with pericontusional vasogenic oedema. They found that dexamethasone treatment resulted in a statistically significant decrease in oedema volume, as well as a decrease in the apparent diffusion coefficient (ADC) and an increase in fractional anisotropy (FA). However, this study focused on vasogenic oedema rather than hypodense areas specifically.

Overall, the available evidence suggests that dexamethasone can improve the level of consciousness and functional status in patients with acute ischemic stroke and brain oedema, but it may not significantly reduce the volume of hypodense areas in the brain. Further research is needed to fully understand the effects of dexamethasone on hypodense areas and its role in stroke treatment.

medshun

Dexamethasone as a treatment for severe strokes

Dexamethasone is a corticosteroid that has been used as an adjunct treatment for severe strokes. Strokes are caused by the blockage of an artery in the brain, which leads to swelling that can cause additional brain cells to die or delay recovery. Corticosteroids are used to reduce this swelling and prevent further damage.

A double-blind study conducted at the Neurological Institute of New York found that dexamethasone improved functional status in patients with severe strokes. The study involved 17 patients treated with a placebo and 14 patients treated with dexamethasone. The patients treated with dexamethasone showed an average improvement of 12%, while those on the placebo got worse by 12%. The benefit of dexamethasone was even more pronounced in the 15 patients most severely affected by their strokes, with the treated group improving by 23% while the placebo group worsened by 14%.

Another study, published in the British Medical Journal, found that dexamethasone did not show a significant difference in the number of survivors or the quality of life at one year when compared to a placebo. However, this study had a smaller sample size of 118 patients and did not specifically focus on severe strokes.

A randomized controlled trial conducted in the departments of medicine of different hospitals in Bangladesh from 2003 to 2006 also showed positive results for dexamethasone in treating acute ischemic stroke with brain oedema. The level of consciousness was compared using the Glasgow Coma Scale (GCS) on the 3rd, 7th, and 10th day of the intervention, and improvement was found to be statistically significant in the dexamethasone-treated group. However, the volume of the hypodense area did not differ significantly between the dexamethasone and control groups in CT scans before and after treatment.

While dexamethasone has shown promise in improving functional status and consciousness in patients with severe strokes, more research is needed to fully understand its effects and determine the optimal treatment regimen.

medshun

Dexamethasone's influence on the functional capacity of patients

Dexamethasone is a potent glucocorticoid with a wide variety of uses in the medical field. It has proven to be useful in treating allergies, inflammation, cerebral oedema, and shock. It has also been used to treat patients with COVID-19, asthma, and dermatitis.

A double-blind study of the effects of dexamethasone on acute stroke was conducted at the Neurological Institute of New York. The study found that patients treated with dexamethasone improved their functional status during the treatment period by an average of 12%, while those treated with a placebo got worse by 12%. The study concluded that dexamethasone can be a useful adjunct to the therapy of patients with severe strokes.

Another study conducted in Bangladesh assessed the effects of dexamethasone on brain oedema following acute ischemic stroke. The study found that dexamethasone improved the level of consciousness in acute ischemic stroke associated with brain oedema but did not reduce the volume of the hypodense area.

However, a review of eight trials involving 466 participants found no benefit of corticosteroids on reducing the number of deaths or improving functional outcomes in survivors of acute ischemic stroke. The review concluded that there is not enough evidence to evaluate corticosteroid treatment for people with acute ischemic stroke.

In summary, while dexamethasone has been found to improve the functional capacity of patients with severe strokes in some studies, the evidence is mixed, and more research is needed to determine its effectiveness in treating acute ischemic stroke.

Frequently asked questions

No, dexamethasone is a prescription medication that can be used to treat inflammation, allergic reactions, flare-ups of ulcerative colitis, adrenal insufficiency, and certain cancers. However, it may increase the risk of bleeding and ulcers in the stomach or intestines, and can worsen congestive heart failure.

Dexamethasone has been found to cause several side effects, including:

- Mood changes

- Trouble sleeping

- Low potassium levels

- Infection

- Eye problems (such as cataracts or glaucoma)

- Increased risk of bleeding

- Congestive heart failure

- Osteoporosis

Dexamethasone has been found to improve the level of consciousness in acute ischemic stroke associated with brain oedema, and can be a useful adjunct to therapy for patients with severe strokes. However, it does not reduce the volume of the hypodense area.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment